首页 | 本学科首页   官方微博 | 高级检索  
检索        

1,25-(OH)2D3对糖尿病大鼠ZO-1表达的影响
引用本文:邹敏书,余健,聂国明,何威逊.1,25-(OH)2D3对糖尿病大鼠ZO-1表达的影响[J].解放军药学学报,2008,24(1):26-29.
作者姓名:邹敏书  余健  聂国明  何威逊
作者单位:1. 广州军区武汉总医院儿科,湖北,武汉,430070
2. 上海交通大学附属儿童医院,肾脏科,上海,200040
摘    要:目的观察糖尿病(DM)大鼠肾小球ZO-1蛋白的表达,1,25-(OH)2D3对ZO-1蛋白表达及分布的影响。方法Wistar大鼠随机分为3组:对照组、糖尿病组(DM组)、1,25-(OH)2D3组。链脲菌素(STZ)腹腔注射建立糖尿病动物模型,1,25-(OH)2D3组在糖尿病建立时即开始渗透性微量泵按3ng/100g·d皮下给予1,25-(OH)2D3,给药10周处死小鼠,检测血糖、半胱氨酸蛋白酶抑制剂(CysC)、尿红细胞、24h尿蛋白定量(24hUPE);光镜观察肾小球细胞数,细胞外基质(ECM)聚积;Western印迹检测ZO-1蛋白的表达;免疫金荧光染色电镜观察肾小球ZO-1分布的改变。结论DM组大鼠CysC、尿红细胞、24hUPE均高于1,25-(OH)2D3组,差异均有统计学意义(P〈0.05)。1,25-(OH)2D3组大鼠较DM组肾小球细胞数减少,细胞外基质聚积减轻(P〈0.05或P〈0.01)。Western印迹示1,25-(OH)2D3组和对照组肾小球ZO-1表达无显著差异,均明显高于DM组(P〈0.01)。免疫金荧光染色显示DM组肾小球ZO-1表达缺失及易位分布明显,1,25-(OH)2D3组ZO-1的表达缺失及易位分布较轻。结论1,25-(OH)2D3可减少尿蛋白的排泄,抑制肾小球细胞数及细胞外基质的增殖,增加足细胞特异蛋白ZO—1的表达,减少其易位,对肾脏有保护作用。

关 键 词:糖尿病  1  25-(OH)2D3  ZO-1
文章编号:1008-9926(2008)01-0026-04
修稿时间:2007年7月23日

Effects of 1,25-Dihydroxyvitamin D3 on the Expression of ZO-1 in the Kidney of Diabetic Rats
ZOU Min-Shu,YU Jian,NIE Guo-Ming,HE Wei-Xun.Effects of 1,25-Dihydroxyvitamin D3 on the Expression of ZO-1 in the Kidney of Diabetic Rats[J].Pharmaceutical Journal of Chinese People's Liberation Army,2008,24(1):26-29.
Authors:ZOU Min-Shu  YU Jian  NIE Guo-Ming  HE Wei-Xun
Institution:ZOU Min-Shu, YU Jian , NIE Guo-Ming, HE Wei-Xun (1Department of Pediatrics,Wuhan General Hospital of Guangzhou Command of PLA,Wuhan 430070,Hubei China;2Deparment of Nephrology,Affiliated Children Hospital of Shanghai Jiaotong University,Shanghai 200040 China)
Abstract:Aim To observe the effects of 1,25-(OH)2D3 on glomerular ZO-1 expression and distribution in the glomeruli of diabetic rats. Methods Wistar rats were randomly divided into the control group, diabetes group (DM group ), and 1,25-(OH)2D3 ( 1,25- ( OH ) 2 D3 group). Diabetes was induced by peritoneal injection of streptozotocin (STZ). Treatment with 1,25-(OH)2D3 ( 3 ng/100g·d) started on the diabetic model by subcutaneous implantation of osmotic minipumps in 1,25-( OH)2D3 group. After administration of 1,25-( OH)2D3 for 10 weeks, the rats were sacrificed, blood sugar ( BG), cystatin C ( Cys C ) , haematuria, 24-hour urinary protein excretion ( 24hUPE ) were measured. Glomerular cells and extracellular matrix (ECM) were observed by light microscope. The expression level of ZO-1 was examined by western blot. The distribution of ZO-1 in glomeruli after immunogold fluorescent staining was observed by electron microscopy. Results Compared with 1,25- (OH)2D3 group, Cys C, haematuria ,24hUPE in DM group were significantly increased ( P 〈 0.05 ). Glomerular cells and the accumulation of ECM in 1,25- (OH) 2D3 group were lower than those in DM group( P 〈 0.05 or P 〈 0.01 ). There was not significant difference in the expression of glomerular ZO-1 between control group and 1,25-( OH)2D3 group, whereas the expression of glomerular ZO-1 in control group and 1,25- (OH)2 D3 group was higher than that of DM group ( P 〈 0.01 ). Histologically ,obvious absence and translocation of the expression of ZO-1 in glomeruli were seen in DM group by immunogold fluorescent staining. The changes were attenuated in 1,25-( OH)2D3 group. Conclusion 1,25-(OH)2D3 could decrease the excretion of proteinuria, inhibit glomerular cells and ECM proliferation, significantly increase the expression and reduce translocation of ZO-1 to protect kidney in diabetic rats.
Keywords:Diabetes  1  25-(OH)2D3  ZO-1
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号